Eiger BioPharmaceuticals, Inc. | Uncategorized | Business Contracts

Offer Letter Agreement, dated as of January 9, 2023, by and between Eiger BioPharmaceuticals, Inc. and David Apelian (Filed With SEC on March 17, 2023)

Open Market Sale AgreementSM, dated March 25, 2022, by and between Eiger BioPharmaceuticals, Inc. and Jefferies LLC (Filed With SEC on March 25, 2022)

Offer Letter Agreement, by and between Eiger BioPharmaceuticals, Inc. and Erik Atkisson, dated as of August 26, 2021 (Filed With SEC on November 4, 2021)

2021 Inducement Plan (Filed With SEC on August 5, 2021)

Open Market Sale AgreementSM, dated August 6, 2020, between Eiger BioPharmaceuticals, Inc. and Jefferies LLC (Filed With SEC on August 6, 2020)

Offer Letter Agreement, by and between the Registrant and Eldon Mayer, dated as of December 3, 2019 (Filed With SEC on May 7, 2020)

Description of Registrants Securities (Filed With SEC on March 13, 2020)

Amended and Restated Offer Letter Agreement, dated as of November 1, 2019, by and between Eiger Biopharmaceuticals, Inc. and David A. Cory (Filed With SEC on November 7, 2019)

Amended and Restated Offer Letter Agreement, dated as of November 1, 2019, by and between Eiger Biopharmaceuticals, Inc. and Sriram Ryali (Filed With SEC on November 7, 2019)

Amended and Restated Offer Letter Agreement, dated as of November 1, 2019, by and between Eiger Biopharmaceuticals, Inc. and Stephana E. Patton (Filed With SEC on November 7, 2019)

Amended and Restated Offer Letter Agreement, dated as of November 1, 2019, by and between Eiger Biopharmaceuticals, Inc. and James Shaffer (Filed With SEC on November 7, 2019)

Offer Letter, dated as of February 26, 2019, by and between Eiger BioPharmaceuticals, Inc. and Stephana Patton (Filed With SEC on May 9, 2019)

Offer Letter, dated as of November 30, 2018, by and between Eiger BioPharmaceuticals, Inc. and Sriram Ryali (Filed With SEC on May 9, 2019)

Eiger BioPharmaceuticals, Inc. (36) | Uncategorized (13)